No abstract

No abstract

The comparison between vascular neoplasms and vascular malformations showed that GLUT1 expression is positive only in infantile hemangiomas, whereas WT1 positivity is found in all vascular neoplasms and in arteriovenous malformations. WT1 antibody is an ancillary test that can be helpful to differentiate vascular neoplasms from most vascular malformations.

This is the first report in the literature investigating WT1 in verrucous hemangioma in order to further clarify the nosology of this vascular anomaly. Despite the clinical features of verrucous hemangioma, which are similar to those seen in vascular malformations, verrucous hemangioma exhibited an immunoprofile similar to vascular neoplasms, according to WT1 and Glut-1 positivity.

Microvenular hemangioma (MH) is a rare benign acquired vascular neoplasm, which can be clinically and histologically misdiagnosed with other vascular lesions. Immunohistochemistry studies in MH are lacking. The aim of this study is to investigate the immunoprofile of MH and gain further insight in its histogenesis. We evaluated 9 cases of MH. Immunohistochemical expression of WT1, GLUT-1, and D2-40 was performed in all cases. All 9 MHs resulted completely positive for WT1 immunostaining. Immunohistochemistry performed in all 9 MH cases showed negative staining for GLUT-1 and D2-40. We added further support to the importance of WT1 as a useful tool in the diagnosis of vascular neoplasms. D2-40 negativity in all tested lesions implied that MH does not exhibit a lymphatic differentiation. GLUT-1, which is characteristically positive in infantile hemangioma and verrucous hemangioma, showed to be negative in MHs.